Viibryd and Vomiting for Women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Vomiting is found for women aged 50-59 who take Viibryd (vilazodone hydrochloride). This study is created by eHealthMe based on reports of 1,001 women aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Viibryd when people have Vomiting
Top conditions
Top co-used drugs
Top other side effects

On Mar, 20, 2026

1,001 women aged 50-59 reported to have side effects when taking Viibryd.
Among them, 42 people (4.2%) have Vomiting

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Vomiting?

Vomiting is found to be associated with 3,794 drugs and 5,734 conditions by eHealthMe. Check the latest studies of Vomiting.

Number of reports submitted per year:

Could Viibryd cause Vomiting in women aged 50-59?

Time on Viibryd when people have Vomiting *

Severity of Vomiting

n/a

How people recovered from Vomiting

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 14.29%
Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 11.90%
Pain: 5 people, 11.90%
High Blood Cholesterol: 5 people, 11.90%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 9.52%
Insomnia (sleeplessness): 4 people, 9.52%
Immunodeficiency Common Variable: 4 people, 9.52%
Nausea (feeling of having an urge to vomit): 4 people, 9.52%
Diabetes: 4 people, 9.52%
Back Pain: 4 people, 9.52%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Diarrhea: 19 people, 45.24%
Nausea (feeling of having an urge to vomit): 19 people, 45.24%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 21.43%
Fever: 8 people, 19.05%
Dizziness: 6 people, 14.29%
Urinary Tract Infection: 6 people, 14.29%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 5 people, 11.90%
Suicidal Ideation: 5 people, 11.90%
Hyperhidrosis (abnormally increased sweating): 5 people, 11.90%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.90%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and have Vomiting?

- Check whether Vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Viibryd and Vomiting

How the study uses the data?

The study is based on (applicable) gender, age, vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.